NIVFW
NewGenIvf Group Limited WarrantsNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.03
52W High
$0.04
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
209.00%
Forward P/E
—
PEG Ratio
—
About NewGenIvf Group Limited Warrants
NewGenIvf Group Limited Warrants (NIVFW) is a pioneering biotechnology firm dedicated to revolutionizing reproductive healthcare through cutting-edge assisted reproductive technology (ART). The company aims to improve success rates and the overall quality of care for individuals and couples experiencing infertility by leveraging innovative research and advanced technologies. Positioned to address significant unmet needs in the fertility market, NewGenIvf is strategically expanding its presence in response to the rising global demand for IVF services, with plans for strategic partnerships and service improvements to enhance patient outcomes.
Fundamentals
| Revenue (TTM) | $4.73M |
| Gross Profit (TTM) | 955,850 |
| EBITDA | $-10.54M |
| Operating Margin | -349.10% |
| Return on Equity | 79.40% |
| Return on Assets | -36.90% |
| Revenue/Share (TTM) | $102.73 |
| Book Value | $110.50 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.90% |
| Shares Outstanding | 0 |
| Float | 568,470 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/5/2026